Investigating the consequences of BCR signalling inhibition on CLL tumour cells of patients treated with ibrutinib BTK inhibitors
Research Project Report (2015-2016)
| Author: | Mr Perry Sissons |
|---|---|
| Supervisor: | Francesco Forconi, Sam Drennan |
| Group: | Haematology |
| Keywords: | ibrutinib, bcr, expression, surface marker, signalling, chronic lymphocytic leukaemia (cll) |